Latest News about BHVN
Recent news which mentions BHVN
From Motley Fool
 
   The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
   
  
  
  May 16, 2022
  From Benzinga
 
   3 Dirt-Cheap Stocks You Can Buy Right Now
   
  
  
  May 14, 2022
  From Motley Fool
 From Benzinga
 
   103 Biggest Movers From Yesterday
   
  
  
  May 11, 2022
  From Benzinga
 From InvestorPlace
 
   Why Biohaven Pharmaceutical Stock Soared Today
   
  
  
  May 10, 2022
  From Motley Fool
 From Benzinga
 From Motley Fool
 From Benzinga
 From Benzinga
 
   77 Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  May 10, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From MarketWatch
 From Benzinga
 
   European Commission Granted Marketing Authorization For Pfizer and Biohaven's VYDURA® (Rimegepant) For Migraine
   
  
  
  April 27, 2022
  From Benzinga
 
   The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
   
  
  
  April 03, 2022
  From Benzinga
 From Benzinga
 
   Biohaven Pharmaceutical's Return On Capital Employed Insights
   
  February 28, 2022
  Tickers 
   BHVN
  
  
  From Benzinga
 
   Biohaven Further Deepens Its Neurology Pipeline With Bristol Myers, Knopp Biosciences Deals
   
  
  
  February 25, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
   
  
  
  February 25, 2022
  From Benzinga
 
   Earnings Scheduled For February 25, 2022
   
  
  
  February 25, 2022
  From Benzinga
 
   The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
   
  
  
  February 20, 2022
  From Benzinga
 
   Biohaven/Pfizer Partnered Rimegepant Asia-Pacific Migraine Trial Meets Primary Endpoints
   
  
  
  February 14, 2022
  From Benzinga
 
   What to Expect From Biogen's $2.3 Billion Shopping Spree
   
  
  
  February 12, 2022
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.